Muscular Dystrophy, Duchenne and Becker Types
What is Muscular Dystrophy, Duchenne and Becker Types?
Duchenne and Becker Muscular Dystrophy is a genetic condition characterized by progressive muscle weakness and atrophy which primarily affects the skeletal and heart muscles.
Last updated 23 Jun 2020, 10:32 PM
23 Jun 2020, 10:32 PM
Check out this story about Terry Horgan, a 24 year old boy, living with muscular dystrophy. Terry’s brother has founded “Cure Rare Disease”, a non profit organization which is currently exploring a treatment for muscular dystrophy. This new gene editing technique is called CRISPR. Watch the video within the provided link to learn more!
Last updated 15 Feb 2010, 10:03 PM
15 Feb 2010, 10:03 PM
I just wanted to say hi and introduce myself. My name is Kim, and I joined because of a close and personal friend of mine, Ryan Ballou. He and his father Ty started a charity called Ballou Skies to help raise awareness and funds to help fund research to prolong the lives of those with Duchenne Muscular Dystrophy. I'm interested to hear how you guys are coping with this condition and what are your hopes, dreams, aspirations and how we can get the word out about the need for research. Please check out the Ballou Skies homepage if you have time and let me know what you think. I would love to hear from you. Thanks.
LELANTOS II Duchenne Muscular Dystrophy Study
Publication date: 11 Feb 2022
Community: Muscular Dystrophy, Duchenne and Becker Types
| Title | Date | Link |
|---|---|---|
| Duchenne Muscular Dystrophy: Consortium.AI wants to cure rare diseases using artificial intelligence - VentureBeat | 07/19/2018 | |
| Meet the family working with scientists to fight rare diseases with CRISPR therapy | 06/21/2020 | |
| A Boy With Muscular Dystrophy Was Headed For A Wheelchair. Then Gene Therapy Arrived | 08/02/2020 | |
| Genethon: green light from the ANSM to start a gene therapy trial for Duchenne Dystrophy | 12/06/2020 | |
| Climbing Mount Everest? A courageous dad fundraises to find cure for a muscle disease in hopes of saving son’s life. | 03/13/2022 | |
| Oxford-Harrington Rare Disease Centre to Advance Novel Treatment for Duchenne Muscular Dystrophy | 08/07/2022 | |
| Cure Rare Disease Scores IND for First-in-Human CRISPR Therapeutic | 08/14/2022 | |
| A 27-year-old with a rare disease has died in an experimental gene-editing study. He was the only volunteer. | 12/03/2022 | |
| The Reasons Why I Share Our Rare Disease Story | 12/24/2022 | |
| FDA advisers narrowly vote in favor of experimental gene therapy for rare muscle disease | 05/14/2023 | |
| FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy | 06/24/2023 | |
| We Speak Duchenne | 03/01/2024 | |
| Neu-REFIX Beta glucan receives rare pediatric disease and orphan drug designations from the US FDA for treatment of Duchenne Muscular Dystrophy | 09/20/2024 |
Clinical Trials
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.
Enrolling is easy.
- Complete the screening form.
- Review the informed consent.
- Answer the permission and data sharing questions.
After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.
Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.
Visit sanfordresearch.org/CoRDS to enroll.
Community Leaders
Expert Questions
Ask a question
Community User List
I'm joining the group because I'm involved with a local charity called Ballou Skies which was started by Ty Ballou and his quest to raise awareness of his son Ryan's condition of...
Start a Community
Don't See Your Condition On Rareshare?
Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.
FAQ
Have questions about rareshare?
Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.
Discussion Forum
Meet the family working with scientists to fight rare diseases with CRISPR therapy
Created by shannon.ashoori | Last updated 23 Jun 2020, 10:32 PM
New To Rareshare
Created by kxd185 | Last updated 15 Feb 2010, 10:03 PM
Our Communities
Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.
FIND YOUR COMMUNITY
Our Resources
Our rare disease resources include e-books and podcasts
Our Community Leaders
Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.